543 related articles for article (PubMed ID: 29211728)
1. An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers.
Airhart SE; Shireman LM; Risler LJ; Anderson GD; Nagana Gowda GA; Raftery D; Tian R; Shen DD; O'Brien KD
PLoS One; 2017; 12(12):e0186459. PubMed ID: 29211728
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide riboside does not alter mitochondrial respiration, content or morphology in skeletal muscle from obese and insulin-resistant men.
Dollerup OL; Chubanava S; Agerholm M; Søndergård SD; Altıntaş A; Møller AB; Høyer KF; Ringgaard S; Stødkilde-Jørgensen H; Lavery GG; Barrès R; Larsen S; Prats C; Jessen N; Treebak JT
J Physiol; 2020 Feb; 598(4):731-754. PubMed ID: 31710095
[TBL] [Abstract][Full Text] [Related]
3. Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults.
Conze D; Brenner C; Kruger CL
Sci Rep; 2019 Jul; 9(1):9772. PubMed ID: 31278280
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans.
Trammell SA; Schmidt MS; Weidemann BJ; Redpath P; Jaksch F; Dellinger RW; Li Z; Abel ED; Migaud ME; Brenner C
Nat Commun; 2016 Oct; 7():12948. PubMed ID: 27721479
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans.
Remie CME; Roumans KHM; Moonen MPB; Connell NJ; Havekes B; Mevenkamp J; Lindeboom L; de Wit VHW; van de Weijer T; Aarts SABM; Lutgens E; Schomakers BV; Elfrink HL; Zapata-Pérez R; Houtkooper RH; Auwerx J; Hoeks J; Schrauwen-Hinderling VB; Phielix E; Schrauwen P
Am J Clin Nutr; 2020 Aug; 112(2):413-426. PubMed ID: 32320006
[TBL] [Abstract][Full Text] [Related]
6. Oral delivery of carrier-free dual-drug nanocrystal self-assembled microspheres improved NAD
Nie H; Zhang Y; Yu H; Xiao H; Li T; Yang Q
Drug Deliv; 2021 Dec; 28(1):433-444. PubMed ID: 33605178
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis.
Pham TX; Bae M; Kim MB; Lee Y; Hu S; Kang H; Park YK; Lee JY
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2451-2463. PubMed ID: 31195117
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide riboside with pterostilbene (NRPT) increases NAD
Simic P; Vela Parada XF; Parikh SM; Dellinger R; Guarente LP; Rhee EP
BMC Nephrol; 2020 Aug; 21(1):342. PubMed ID: 32791973
[TBL] [Abstract][Full Text] [Related]
9. Targeting sirtuin activity with nicotinamide riboside reduces neuroinflammation in a GWI mouse model.
Joshi U; Evans JE; Pearson A; Saltiel N; Cseresznye A; Darcey T; Ojo J; Keegan AP; Oberlin S; Mouzon B; Paris D; Klimas N; Sullivan K; Mullan M; Crawford F; Abdullah L
Neurotoxicology; 2020 Jul; 79():84-94. PubMed ID: 32343995
[TBL] [Abstract][Full Text] [Related]
10. Nicotinamide riboside supplementation does not alter whole-body or skeletal muscle metabolic responses to a single bout of endurance exercise.
Stocks B; Ashcroft SP; Joanisse S; Dansereau LC; Koay YC; Elhassan YS; Lavery GG; Quek LE; O'Sullivan JF; Philp AM; Wallis GA; Philp A
J Physiol; 2021 Mar; 599(5):1513-1531. PubMed ID: 33492681
[TBL] [Abstract][Full Text] [Related]
11. Nicotinamide riboside attenuates alcohol induced liver injuries via activation of SirT1/PGC-1α/mitochondrial biosynthesis pathway.
Wang S; Wan T; Ye M; Qiu Y; Pei L; Jiang R; Pang N; Huang Y; Liang B; Ling W; Lin X; Zhang Z; Yang L
Redox Biol; 2018 Jul; 17():89-98. PubMed ID: 29679894
[TBL] [Abstract][Full Text] [Related]
12. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease.
Brakedal B; Dölle C; Riemer F; Ma Y; Nido GS; Skeie GO; Craven AR; Schwarzlmüller T; Brekke N; Diab J; Sverkeli L; Skjeie V; Varhaug K; Tysnes OB; Peng S; Haugarvoll K; Ziegler M; Grüner R; Eidelberg D; Tzoulis C
Cell Metab; 2022 Mar; 34(3):396-407.e6. PubMed ID: 35235774
[TBL] [Abstract][Full Text] [Related]
13. Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside.
Mateuszuk Ł; Campagna R; Kutryb-Zając B; Kuś K; Słominska EM; Smolenski RT; Chlopicki S
Biochem Pharmacol; 2020 Aug; 178():114019. PubMed ID: 32389638
[TBL] [Abstract][Full Text] [Related]
14. Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD
Elhassan YS; Kluckova K; Fletcher RS; Schmidt MS; Garten A; Doig CL; Cartwright DM; Oakey L; Burley CV; Jenkinson N; Wilson M; Lucas SJE; Akerman I; Seabright A; Lai YC; Tennant DA; Nightingale P; Wallis GA; Manolopoulos KN; Brenner C; Philp A; Lavery GG
Cell Rep; 2019 Aug; 28(7):1717-1728.e6. PubMed ID: 31412242
[TBL] [Abstract][Full Text] [Related]
15. Nicotinamide riboside, a form of vitamin B3 and NAD+ precursor, relieves the nociceptive and aversive dimensions of paclitaxel-induced peripheral neuropathy in female rats.
Hamity MV; White SR; Walder RY; Schmidt MS; Brenner C; Hammond DL
Pain; 2017 May; 158(5):962-972. PubMed ID: 28346814
[TBL] [Abstract][Full Text] [Related]
16. Safety and Tolerability of Nicotinamide Riboside in Heart Failure With Reduced Ejection Fraction.
Wang DD; Airhart SE; Zhou B; Shireman LM; Jiang S; Melendez Rodriguez C; Kirkpatrick JN; Shen DD; Tian R; O'Brien KD
JACC Basic Transl Sci; 2022 Dec; 7(12):1183-1196. PubMed ID: 36644285
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide Riboside, an NAD + Precursor, Protects Against Cardiac Mitochondrial Dysfunction in Fetal Guinea Pigs Exposed to Gestational Hypoxia.
Thompson LP; Song H; Hartnett J
Reprod Sci; 2024 Apr; 31(4):975-986. PubMed ID: 37957471
[TBL] [Abstract][Full Text] [Related]
18. Safety Assessment of High-Purity, Synthetic Nicotinamide Riboside (NR-E) in a 90-Day Repeated Dose Oral Toxicity Study, With a 28-Day Recovery Arm.
Marinescu AG; Chen J; Holmes HE; Guarente L; Mendes O; Morris M; Dellinger RW
Int J Toxicol; 2020; 39(4):307-320. PubMed ID: 32715855
[TBL] [Abstract][Full Text] [Related]
19. A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment.
Orr ME; Kotkowski E; Ramirez P; Bair-Kelps D; Liu Q; Brenner C; Schmidt MS; Fox PT; Larbi A; Tan C; Wong G; Gelfond J; Frost B; Espinoza S; Musi N; Powers B
Geroscience; 2024 Feb; 46(1):665-682. PubMed ID: 37994989
[TBL] [Abstract][Full Text] [Related]
20. Dihydronicotinamide riboside is a potent NAD
Yang Y; Mohammed FS; Zhang N; Sauve AA
J Biol Chem; 2019 Jun; 294(23):9295-9307. PubMed ID: 30948509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
